|

Cardiac Autonomic Dysfunction As a Sign of Irreversible Advanced Heart Failure

RECRUITINGSponsored by University Hospital Bispebjerg and Frederiksberg
Actively Recruiting
SponsorUniversity Hospital Bispebjerg and Frederiksberg
Started2024-08-01
Est. completion2025-06-30
Eligibility
Age18 Years+
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT06532825

Summary

The main hypothesis is that autonomic dysfunction cannot improve among patients reaching end-stage heart failure. To evaluate this, patients admitted with acute decompensated heart failure in Bispebjerg hospital, and history one or more admissions with the same condition within the prior year, will undergo repeated brief heart monitoring (10 min). Baseline recordings (at admission) will be compared with equivalent measurements before discharge to explore whether heart rate variability increases. Patients will be followed for six months after discharge from the hospital.

Eligibility

Age: 18 Years+Healthy volunteers accepted
Inclusion Criteria:

* 18-years age or older
* admitted with acute decompensated heart failure for less than 48 h

Exclusion Criteria:

* pacemaker
* not signed informed consent
* other heart rhythm than sinus rhythm or atrial fibrillation

Conditions2

Heart DiseaseHeart Failure

Browse More Trials

Heart Disease trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.